Comparison of EBOV GP IgG antibody reactivity: Results from two immunoassays in the Democratic Republic of the Congo

Ebola virus (EBOV) is a highly infectious pathogen, and its long-term consequences continue to be investigated. With its high fatality rate and potential for reinfection or latent infection, continued development of research tools is of utmost importance. Using a cohort (n = 503) of existing bio-ban...

Full description

Saved in:
Bibliographic Details
Published in:Journal of virological methods 2025-07, Vol.336, p.115154, Article 115154
Main Authors: Merritt, Sydney, Halbrook, Megan, Kompany, Jean Paul, Chandrasekaran, Prabha, Smith, Olivia A., Hoff, Nicole A., Tambu, Merly, Martin, Skylar A., Wong, Teri Ann, Jarra, Amie, Barrall, Angelica L., Musene, Kamy, Beya, Michael, Orr, Robert, Myers, Todd, MacGill, Tracy, Hensley, Lisa E., Muyembe-Tamfum, Jean-Jacques, Kaba, Didine, Berry, Irina Maljkovic, Mbala-Kingebeni, Placide, Lehrer, Axel T., Rimoin, Anne W.
Format: Article
Language:English
Subjects:
Adolescent
Adult
animals
antibodies
Antibodies, Viral - blood
antibody detection
carrier state
Cohort Studies
Democratic Republic of the Congo
Ebolavirus
Ebolavirus - immunology
EBOV GP
Female
glycoproteins
Hemorrhagic Fever, Ebola - diagnosis
Hemorrhagic Fever, Ebola - epidemiology
Hemorrhagic Fever, Ebola - immunology
Humans
immune response
Immunoassay - methods
Immunoassays
immunoglobulin G
Immunoglobulin G - blood
innate immunity
Male
Middle Aged
mortality
pathogens
Serosurveillance
Viral Envelope Proteins - immunology
Young Adult
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!